Greater understanding of the basic biology of the cancer cell has provided new avenues for
research in malignant lymphomas. Despite these advances, however, several challenges …

The lymphomas are a heterogeneous group of cancers that have played a prominent role in
the history of oncology, being among the first cancers to respond to radiotherapy or systemic …

Part of the acclaimed ACS Atlas of Clinical Oncology series, this book is designed to
summarize current knowledge on the pathology, epidemio logy, molecular biology …

Over recent years, there has been a dramatic increase in knowledge of the biology of the
lymphomas which has been accompanied by the emergence of new treatments that offer …

The lymphomas are a diverse group of malignant disorders that vary with respect to their
molecular features, genetics, clinical presentation, treatment approaches, and outcome …

Historically, the treatment of patients with lymphoma has been based on three columns, with
ascending importance: surgery, radiation, and chemotherapy. However, in recent years, the …

The knowledge that a group of closely related neoplasms, the lymphomas, originated in the
mutation of protoncogenes in a single lymphocyte resulted from several principal antecedent …

The classification of both Hodgkin's and non‐Hodgkin's lymphomas continues to evolve. The
current World Health Organization classification incorporates data derived from advances in …

Our ability to manage patients with non-Hodgkin lymphoma and Hodgkin lymphoma has
improved dramatically in the past decade. The survival of patients with the two most frequent …

Today, lymphoma represents one of the most complex and diverse malignancies in routine
clinical practice and huge advances have been made in the pathological classification and …